BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, January 25, 2025
See today's BioWorld MedTech
Home
» Agreements/contracts: BD Diag, Lab21 in accord to develop cancer detection assays
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Agreements/contracts: BD Diag, Lab21 in accord to develop cancer detection assays
Oct. 16, 2012
By
Omar Ford
No Comments
It only took one successful assay developed by BD Diagnostics (Circle Sparks, Maryland) and Lab21 (Cambridge, UK), for both firms to realize they had something special when it comes to working together to get new products to market.
BioWorld MedTech